Prevention of unintentional overexposure in topical psoralen treatment of vitiligo.
D001577:Benzophenones / Q000627:therapeutic use*; D003374:Coumarins / Q000009:adverse effects*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D010787:Photosensitivity Disorders / Q000139:chemically induced / Q000517:prevention & control*; D010859:Pigmentation Disorders / Q000139:chemically induced / Q000517:prevention & control*; D014820:Vitiligo / Q000188:drug therapy*
D001577:Benzophenones; D003374:Coumarins; D003879:Dermatologic Agents